Damion J. Boyer

Damion J. Boyer is a seasoned professional with extensive experience in the healthcare and medical device sectors. As Co-Founder of Corvidane since June 2014, Boyer has been instrumental in developing a drug aimed at treating both Atherosclerosis and Metabolic Dysfunction-Associated Steatohepatitis (MASH). Boyer also co-founded INROADS, contributing to its mission since 1987. Previous roles include Venture Partner at FundRx, where Boyer supported investments in early-stage healthcare and life sciences companies, and positions at Maquet Getinge Group, TranS1, and Medtronic, where responsibilities spanned from sales management to territory management. Boyer began a career in engineering at Eaton Corporation after earning a B.S. in Mechanical Engineering from Case Western Reserve University, where education was completed from 1988 to 1992.